Purchases and Sales Made in Q2 2025 in Inmune Bio, Inc. (INMB)
This table provides information about the institutional ownership of Inmune Bio, Inc. (INMB) during Q2 2025. The information is specifically focused on institutions that hold shares of Inmune Bio, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2025
Q2 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-17.1K- 42.04% |
$39.5K - $141K
|
23.6K
$57.1K
|
|
|
Aug 14, 2025
Q2 2025
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-18.2K- 59.95% |
$42.1K - $150K
|
12.2K
$29.5K
|
|
|
Aug 14, 2025
Q2 2025
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-20.4K- 50.5% |
$47K - $168K
|
19.9K
$48.3K
|
|
|
Aug 12, 2025
Q2 2025
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-37.7K- 99.22% |
$87.1K - $312K
|
296
$716
|
|
|
Aug 14, 2025
Q2 2025
|
Raymond James Financial Inc
St. Petersburg, FL |
SELL
|
- |
-48.6K- 12.71% |
$112K - $401K
|
333K
$807K
|
|
|
Aug 05, 2025
Q2 2025
|
Westside Investment Management, Inc.
|
SELL
|
- |
-67.8K- 76.04% |
$157K - $560K
|
21.4K
$51.7K
|
|
|
Aug 14, 2025
Q2 2025
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-199K- 82.34% |
$459K - $1.64M
|
42.6K
$103K
|